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Abstract Vestibular schwannomas show a large variation
in growth rate, making prediction and anticipation of tumor
growth difficult. More accurate prediction of clinical behav-
ior requires better understanding of tumor biological factors
influencing tumor progression. Biological processes like
intratumoral hemorrhage, cell proliferation, microvessel
density, and inflammation were analyzed in order to deter-
mine their role in vestibular schwannoma development.
Tumor specimens of 67 patients surgically treated for a
histologically proven unilateral vestibular schwannoma
were studied. Preoperative magnetic resonance imaging
(MRI) scans were used to determine tumor size and to
classify tumors as homogeneous, inhomogeneous, and cys-
tic. Immunohistochemical studies evaluated cell prolifera-
tion (histone H3 and Ki-67), microvessel density (CD31),
and inflammation (CD45 and CD68). Intratumoral hemor-
rhage was assessed by hemosiderin deposition. The expres-
sionpatternsofthesemarkerswerecomparedwithtumorsize,
tumor growth index, MRI appearance, patients’ age, and
duration of symptoms. No relation between cell proliferation
and clinical signs of tumor volume increase or MRI appear-
ance was found. Intratumoral hemosiderin, microvessel den-
sity, and inflammation were significantly positively correlated
with tumor size and the tumor growth index. Cystic and
inhomogeneous tumors showed significantly more hemosid-
erin deposition than homogeneous tumors. The microvessel
density was significantly higher in tumors with a high number
of CD68-positive cells. The volume increase of vestibular
schwannomas is not based on cell proliferation alone. Factors
like intratumoral bleeding, (neo)vascularization, and intensity
of the inflammatory reaction also influence tumor volume.
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Introduction
Vestibular schwannomas (acoustic neuromas) are benign
tumors originating from the myelin-forming Schwann cells
of the vestibular branch of the eighth cranial nerve in the
internal auditory canal or cerebellopontine angle. Clinically,
these tumors grow slowly and progressively, eventually
causing brainstem compression.
One of the problems in the treatment of these tumors is
the large variation in the evolution of increase in volume in
time. Why this is so variable remains largely unknown, but
clinically, this makes prediction and anticipation of the
evolution of symptoms difficult. Current therapeutic man-
agement is mainly based on symptoms and radiological
assessment. Unfortunately, these indicators do not always
correlate with actual tumor volume increase. More accurate
prediction of tumor expansion rate could lead to more
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when a vestibular schwannoma is diagnosed.
Accurate assessment of potential tumor volume increase
requires better understanding of tumor biological (growth)
factors and concurrent pathological events like cyst forma-
tion. To gain more insight in the role of these factors, we
assessed the relationships between (immuno)histopatholog-
ical markers, radiological observations on tumor appear-
ance, and clinical growth of vestibular schwannomas.
One way for tumors to expand is by cell proliferation. A
well-known proliferation marker is the Ki-67 antigen [1, 2],
which is present during all phases of the cell cycle but is
absent in noncycling cells. A less known indicator for pro-
liferation is the phosphorylated histone H3 protein, which is
expressed during mitosis [3–5]. Both these markers were
included in this study.
In addition to proliferation, we investigated to what
extent intratumoral hemorrhage, microvessel density, and
the degree of inflammation are involved in tumor expansion.
To quantify intratumoral hemorrhage, hemosiderin (i.e.,
iron) deposition was evaluated. The endothelial marker
CD31 was used to measure microvessel density, and the
degree of inflammation was determined by quantifying the
number of leukocytes and macrophages through the expres-
sion of the markers CD45 and CD68, respectively.
Material and methods
Patients
From the vestibular schwannoma database at the Leiden
University Medical Center, a total of 67 patients (26 males
and 41 females) were identified. They involved a group of
patients surgically treated for a histologically proven vestib-
ular schwannoma from January 2000 to November 2005.
The main criteria for surgical treatment were clinical symp-
toms (e.g., progressive or debilitating vertigo and hearing
loss) and tumor size, both initial as well as in terms of
progression over time. Patients’ personal preference was
also of great importance in deciding if and when to apply
treatment. Only cases of unilateral sporadic schwannomas
were selected, patients diagnosed with NF2 were excluded.
Tumor measurement
Information on radiological data was obtained from radiol-
ogy records which are all composed according to specific
clinical and scientific incentives. These standardized reports
include measurement of the greatest tumor diameter accord-
ing to the guidelines of the American Academy of Otolar-
yngology Head and Neck Surgery [6]. Additionally, the
reports comprise evaluation of tumor density based on
gadolinium-enhanced T1-weighted as well as T2-weighted
scans. Depending on the presence of microcystic and or
macrocystic components, tumors were classified as homo-
geneous, inhomogeneous, or cystic. All patient data were
prospectively discussed at a multidisciplinary conference
attended by representatives of the neurosurgery, radiology,
radiotherapy, pathology, and otolaryngology department.
Clinical and radiological data were cross checked before
being entered in the vestibular schwannoma database (for
the exact patient characteristics, including figures illustrating
cystic, inhomogeneous, and homogeneous tumors, see
Electronic supplementary material Figs. 1, 2,a n d3).
Immunohistochemistry
The immunohistochemical tests were conducted at the
Department of Pathology of the Leiden University Medi-
cal Center. The tests were conducted on specimens pre-
served in formalin and stored in paraffin. All assessments
were performed on tissue sections obtained from one
single tumor block per tumor sample. Immunohistochem-
ical reactions were performed according to standard labo-
ratory methods [7]. In brief, heat-induced antigen retrieval
was performed using microwave treatment of all sections
after dewaxing and rehydration, followed by blocking of
endogenous peroxidase with 3 % H2O2 in methanol. In-
cubation with primary antibodies was overnight (for sour-
ces, working dilutions, and positive controls used, see
Table 1). Subsequently, sections were incubated with
poly-HRP-antimouse/rabbit/rat conjugate. Visualization
was carried out with a H2O2–diaminobenzidine solution.
All washing procedures were performed in phosphate-
buffered saline. Slides were counterstained with hematox-
ylin. In addition to the immunohistochemical stains,
hemosiderin staining was performed.
Microscopic analysis
In order to obtain an overall impression of the staining
pattern of each marker, all sections were first evaluated
using a × 10 objective lens. Hemosiderin, CD45, and
CD68 displayed an irregular/patchy staining pattern, making
Table 1 Antibody concentrations and positive control tissues used
Antibody Supplier Concentration Positive control
Ki-67 DAKO 1:800 Tonsil
Histone H3 Comproscientific 1:3,200 Tonsil
CD31 DAKO 1:150 Tonsil
CD45 DAKO 1:4,000 Tonsil
CD68 DAKO 1:20,000 Tonsil
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further analysis of these markers was performed manually
in a semiquantitative score. Per specimen, 10 randomly
chosen fields of view (FOV) were evaluated at a × 40
objective lens. Scoring was independently assessed by two
authors. The degree of staining was scored as follows: 0,
absent; 1, mild; and 2, strong.
Staining for Ki67 and histone H3 showed a more
homogeneous distribution, permitting the application of
a computer-based image analysis method in order to
determine the index of proliferation. In brief, of each
specimen, five randomly chosen digital snapshots were
taken. Positively stained nuclei were identified through
spectrometry using a Leica DM4000B microscope fitted
with a CRI Nuance spectral analyzer (Cambridge Re-
search and Instrumentation, Inc., Woburn, MA, USA).
Using Mirax software (Zeiss, Germany) and ImageJ
(National Institutes of Health, Bethesda, MD, USA),
the number of pixels representing positively stained
nuclei was determined, as well as the number of pixels
representing the total nuclear area in one FOV. The
index of proliferation was calculated by dividing the
number of immunopositive pixels by the number of
pixels representing the total nuclear area. The mean
value of the five snapshots was used for statistical
analysis.
Microvessel density was determined with the Chalkley
point overlap morphometric technique, which allows for
rapid analysis with a relatively low interobserver variability
[8]. This method has been described in detail [9, 10]. In
brief, CD31 stained sections were scanned for hot spots of
high vascular density. Using an ocular grid with 25 random
points, microvessel density was scored in these hot spots
with a × 20 objective lens. The grid was oriented to permit
the maximum number of points to hit the stained micro-
vessels (Fig. 1). The Chalkley count was the mean of the
maximum number of points hitting a microvessel in three
hot spots per tumor specimen.
Tumor growth index
Accurate measurement of tumor growth depends on serial
magnetic resonance imaging (MRI) scanning over a longer
period of time. Because only six patients in our selection
underwent serial MRI scanning prior to surgery, this method
of growth assessment could not be used in our study. We
used the tumor growth index as a surrogate parameter. This
index has been described earlier regarding vestibular
schwannoma growth [11, 12]. Its basic assumption is that
the age of onset of the tumor varies randomly. The tumor
growth index is calculated by dividing the maximal tumor
diameter by the age of the patient.
Statistical analysis
For evaluation of the relationships between the tumor bio-
logical markers and parameters of clinical growth, the
Spearman rank correlation test was used. The difference in
hemosiderin deposition between cystic and inhomogeneous
tumors versus homogeneous tumors was determined by the
chi-square test. Tumor size of cystic and inhomogeneous
tumors versus homogeneous tumors was compared with the
unpaired t test. The relation between microvessel density
and CD68 expression was evaluated using the one-way
Fig. 1 Examples of Chalkley counts in vascular hotspots, specimen a
and b score 10 and 6, respectively (original magnification×200)
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statistical tests, p<0.05 was considered as significant. All
calculations were performed using SPSS Inc. software,
version 17.0.
Results
A total of 67 patients (age: range, 15–72 years; mean, 49.04±
14.06 years) was studied. Maximum tumor diameter varied
between 5 and 50 mm (mean, 24.03±11.52 mm) and the
tumor growth index (which does not represent actual increase
in size but a parameter for tumor growth rate) varied between
0.07 and 2.11 mm/year (mean, 0.56±0.40 mm/year).
The mean value of the Ki-67 index in this studied group
was 0.6 % (range, 0.1–1.8 %). For the histone H3 index, the
mean value was 3.9 % (range, 0.4–15.5 %). No significant
correlation was found between the Ki-67 or histone H3
index and maximal tumor diameter, tumor growth index,
and radiologically measured tumor growth.
The number and distribution of hemosiderin-, CD45-,
and CD68-positive cells in the tissue sections were very
heterogeneous. Some specimens showed no staining at all,
yet other specimens showed a substantial number of positive
cells (Fig. 2). The mean Chalkley count was 9.59 (range,
3.3–23.0; SD, 3.70). The Spearman rank correlation test
demonstratedseveral significantpositivecorrelationsbetween
these markers (Table 2, for the corresponding scattergrams,
see Electronic supplementary material Figs. 4, 5,a n d6).
The number of hemosiderin-positive cells correlated with
tumor size (p<0.001; r00.39) and tumor growth index
(p<0.006; r00.33). CD45 expression correlated with tumor
size (p<0.006; r00.33) and tumor growth index (p<0.002;
r00.38), and CD68 expression also correlated with tumor
size (p<0.0001;r00.46) and tumor growth index (p<0.0001,
r00.48).
The Chalkley count demonstrated a positive correlation
with tumor size (p<0.001; r00.40) and tumor growth index
(p<0,002; r00.37). Furthermore, the Chalkley count
showed a significant correlation with the number of
hemosiderin-positive cells (p<0.003; r00.36), CD45-
positive cells (p<0.021 r00.28), and CD68-positive cells
(p<0.0001; r00.47). A one-way ANOVA and a Scheffe test
confirmed the positive relation between the number of
CD68-positive cells and microvessel density. Tumors with
a high number of CD68-positive cells displayed a signifi-
cantly higher microvascular density than tumors with low or
no CD68-positive cells (Fig. 3).
In 61 patients, the tumors were morphologically classi-
fied based on their MRI appearance. Twenty-four tumors
were classified as homogeneous, 8 as inhomogeneous, and
29 as cystic. Cystic and inhomogeneous tumors were sig-
nificantly larger than homogeneous tumors (Table 3). Cystic
and inhomogeneous tumors also displayed a significantly
higher number of hemosiderin-positive cells than homoge-
neous tumors (Table 3).
No statistically significant correlations or differences
were observed when patient age or duration of symptoms
was taken into account.
Discussion
To gain more insight into the mechanisms responsible for
volume increase of vestibular schwannomas, possible corre-
lations between histopathological markers and radiological
and clinical characteristics of vestibular schwannomas were
investigated. For studying the growth rate of a tumor, serial
radiological observation is the preferred method. As most
patients in this study were operated on shortly after diagno-
sis, in the majority of cases, only one preoperative MRI scan
was obtained, which excluded this approach. As a surrogate,
we used the growth index, which is only a rough estimate of
the rate of tumor volume increase but allowed us to include
a larger number of patients in the study.
To evaluate the role of proliferative activity in the volume
increase of vestibular schwannomas, the cell cycle markers
Ki-67 and histone H3 were used. Ki-67 as a parameter of
growth of vestibular schwannomas has been studied by
Niemczyk et al. [2], who compared clinically stable vestib-
ular schwannomas with clinically growing cases. They
found a significant difference in Ki-67 labeling index be-
t w e e nt h et w og r o u p s .T h em ean labeling index in the
growing tumors was 3.17 % compared to 1.11 % in the
stable tumors. Overall, the Ki-67 index ranged from 0.22 to
5 %, with an average of 1.86 %. Gomez et al. [13] also
investigated cell proliferation in vestibular schwannomas,
but did not find a significant correlation between tumor
growth and Ki-67 labeling index, which ranged from 0.2
to 2.2 %. We conclude that the labeling index of Ki-67 in
our study (ranging from 0.1 to 1.8 %, with a mean of 0.6 %)
is comparable with earlier published data.
Histone H3 as a proliferation marker has not been studied
in vestibular schwannomas before. We did not find a corre-
lation between the histone H3 labeling index and the tumor
growth index. Taken together, our data and those from the
literature indicate that cell proliferation is not a decisive
factor in the expansion of vestibular schwannomas.
Degenerative changes such as cysts may contribute to
tumor volume increase. Reports on the incidence of cyst
formation in vestibular schwannomas vary between 5.7 and
48 %, with more recent studies indicating incidences of
approximately 10 % [14–17]. Cystic tumors can display a
relatively rapid increase in volume and generally become
larger than noncystic tumors [18]. This also applies to our
case series, the cystic and inhomogeneous tumors being
632 Virchows Arch (2012) 460:629–636significantly larger than the homogeneous tumors. The
mechanisms responsible for cyst formation in vestibular
schwannomas remain unclear. Gomez et al. [13] demonstrat-
ed a significant correlation between hemosiderin deposition,
tumor size, and tumor heterogeneity and suggested that
hemosiderin resorption might induce cyst formation. The
same suggestion is made by Park et al. [19]. Our results
are in line with these studies. We found significantly more
hemosiderin deposition in cystic and inhomogeneous
tumors compared to homogeneous tumors. The significant
correlations between hemosiderin deposition and tumor size
and tumor growth index also support this notion.
These results may offer a clue in the search for markers of
tumor volume increase. Both cysts and iron deposition are
radiologically demonstrable and might, therefore, constitute
clinicallyapplicablemarkers. Aradiologicalstudyonpituitary
macroadenomas by Stadlbauer et al. [20] described a signifi-
cant difference in spectral signals measured in hemorrhagic
versusnonhemorrhagictumors.Theauthorssuggestedthatthe
paramagnetic effect of hemosiderin deposition in hemorrhagic
Fig. 2 a Proliferating cells (Ki-67/histone H3), b intratumoral bleeding (hemosiderin), c high microvessel density (CD31), and d intratumoral
inflammation (CD45/CD68) (original magnification×400)
Table 2 Spearman’s correlation
test for pathological markers and
clinical characteristics
TGI tumor growth index, MVD
microvessel density
aHemosiderin
Ki-67 Histone H3 CD45 CD68 Siderin
a MVD
Size Correlation coefficient 0.129 0.326 0.333** 0.457** 0.392** 0.397**
Significance (two-tailed) 0.301 0.120 0.006 0.000 0.001 0.001
TGI Correlation coefficient 0.091 0.275 0.375** 0.482** 0.330** 0.373**
Significance (two-tailed) 0.466 0.243 0.002 0.000 0.006 0.002
MVD Correlation coefficient 0.140 0.240 0.281* 0.472** 0.363** –
Significance (two-tailed) 0.261 0.102 0.021 0.000 0.003 –
Virchows Arch (2012) 460:629–636 633tumors on the MR images might provide an explanation.
Using this approach to study iron deposition and cyst forma-
tion in vestibular schwannomas might establish a causal rela-
tionshipbetweenintratumoralhemorrhageandcystformation.
Although vestibular schwannomas are relatively slow-
growing neoplasms, they depend for further growth on a
functional vascular system, as any other tumor [21]. The
positive correlation between microvessel density and tumor
size and tumor growth index we found is consistent with
other published data [22, 23]. These findings suggest that
angiogenesis may be important for the volume increase of
vestibular schwannomas. Determining the degree of vascu-
larization of vestibular schwannomas might also be possible
using MRI diffusion or perfusion techniques [24–26]. Fur-
ther research into this hypothesis could lead to another
clinically applicable marker of tumor volume increase.
These results also suggest that antiangiogenesis therapy
might contribute to controlling tumor growth.
The degree of inflammation measured by the expression
of CD68 and CD45 showed a positive significant correlation
with tumor size and tumor growth index. Similar correla-
tions have not been reported in the literature yet. In a study
performed by Brieger el al. [27] on angiogenic growth
factors in vestibular schwannomas, tumor-infiltrating
CD68-positive lymphocytes were not detected. Labit et al.
[28] only found a correlation between the number of CD45-
positive cells and the duration of symptoms. The mechanism
responsible for or the significance of an inflammatory reac-
tion in vestibular schwannomas has not been elucidated as
yet. Studies on breast cancer have addressed the role of the
inflammatory microenvironment in tumor progression
[29–35]. It has been proposed that inflammation which
triggers angiogenesis might contribute to tumor progression.
Macrophage activity is a major determinant of the intra-
tumoral inflammatory milieu but other components of the
inflammatory infiltrate also seem to modulate tumor behav-
ior [36]. The significant associations between the degree of
inflammation (i.e., CD45 and CD68) and tumor size and
tumor growth index and, in addition, the significant increase
of microvessel density in tumors with a higher number of
CD68-positive cells (Fig. 3) suggest that similar processes
take place in vestibular schwannomas. Several approaches
targeting macrophage activity are currently under investiga-
tion [37, 38], making additional research of the inflammatory
Fig. 3 Relation between CD68
expression and microvessel
density. The mean Chalkley
count is significantly higher in
tumors with strong CD68
expression. Asterisk denotes
statistical differences calculated
with the Scheffe test
Table 3 MRI appearance compared by hemosiderin deposition and size
MRI Hemosiderin deposition
a Size
b
Absent Mild Strong χ
2 df p value Mean ± SD p value
Homogeneous 15 7 2 8.67 2 <0.013 13.46±8.44 <0.0001
Inhomogeneous/cystic 10 15 12 30.46±8.43
MRI magnetic resonance imaging
aChi-square test
bIndependent t test
634 Virchows Arch (2012) 460:629–636process in vestibular schwannomas even more interesting.
The first step would be further typing of inflammatory cells
present in vestibular schwannomas. Furthermore, their activa-
tion state and relationship with angiogenic growth factors
should be examined.
The results of this study indicate that tumor volume
increase of vestibular schwannomas is not based on cell
proliferation alone. Contributing factors are intratumoral
hemorrhage, vascularization, and degree of inflammation.
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